LOBE logo

Lobe Sciences Ltd. Stock Price

CNSX:LOBE Community·CA$18.9m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

LOBE Share Price Performance

CA$0.07
0.05 (180.00%)
CA$0.07
0.05 (180.00%)
Price CA$0.07

LOBE Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with slight risk.

4 Risks
0 Rewards

Lobe Sciences Ltd. Key Details

CA$0

Revenue

CA$0

Cost of Revenue

CA$0

Gross Profit

CA$4.4m

Other Expenses

-CA$4.4m

Earnings

Last Reported Earnings
Aug 31, 2025
Next Reporting Earnings
n/a
-0.016
0%
0%
5.6%
View Full Analysis

About LOBE

Founded
2018
Employees
n/a
CEO
Frederick Sancilio
WebsiteView website
www.lobesciences.com

Lobe Sciences Ltd., a biopharmaceutical company, engages in the research and development of lipid technology to develop innovative treatments for orphan and rare diseases. It offers Altemia® MF, a medical food designed to manage deficiencies in sickle cel disease. Lobe Sciences Ltd. was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. The company was founded in 2018 and is headquartered in Vancouver, Canada.

Recent LOBE News & Updates

Recent updates

No updates